Kidney transplantation reduces the risk of chronic limb threatening ischemia and amputation among patients with end-stage renal disease on hemodialysis

被引:1
|
作者
Galarza Tapia, Andres [1 ]
Velescu, Alina [1 ,2 ,3 ]
Collado Nieto, Silvia [4 ]
Cao Baduell, Higinio [4 ]
Ruiz-Carmona, Carlos [1 ]
Mateos Torres, Eduardo [1 ]
Redondo Pachon, Maria Dolores [4 ]
Clara Velasco, Albert [1 ,2 ,3 ,5 ]
机构
[1] Hosp Mar, Angiol & Vasc Surg Dept, Barcelona, Spain
[2] Inst Hosp Mar Invest Med IMIM, Barcelona, Spain
[3] CIBER Enfermedades Cardiovasc, Barcelona, Spain
[4] Hosp Mar, Nephrol Dept, Barcelona, Spain
[5] Univ Autonoma Barcelona, Surg Dept, Barcelona, Spain
关键词
chronic limb threatening ischemia; kidney transplantation; hemodialysis; PERIPHERAL ARTERIAL-DISEASE; LOWER-EXTREMITY AMPUTATION; DIABETIC-PATIENTS; FOOT ULCERATION; PREVALENCE; MORTALITY; IMPACT;
D O I
10.1177/17085381221078176
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective This study aimed to analyze the risk of chronic limb threatening ischemia (CLTI) or amputation among patients with end-stage renal disease (ESRD) entering a hemodialysis (HD) program and to evaluate the protective effect associated with kidney transplantation (KT). Design, Material and Methods Retrospective cohort of all consecutive ESRD patients entering into a HD program at our institution between 2000 and 2010. Collected variables included baseline characteristics (pre-entry in hemodialysis), time on HD program, KT and the composite outcome of chronic limb threatening ischemia or need for any amputation (CLTI/AMP). Patients with previous symptomatic peripheral arterial disease or amputation were excluded. Results The study group included 336 patients (mean age 63 years, 66% male). The mean follow up was 6.7 years with an average time on HD of 4.2 years. Ninety two patients (27.4 %) underwent transplantation. CLTI free survival rates were 90.3 % and 82.6 % at 5 and 10 years, respectively. The episodes of CLT involved 28 revascularization procedures (17 endovascular and 11 open surgeries), 18 minor amputations and 20 major amputations. KT was associated with a protective effect over the development of CLTI (HR: 0.065; CI 95% 0.02-0.21) after adjustment for confounding factors. The long-term survival of non-transplanted patients was 45 % and 15 % at 5 and 10 years, respectively and the long-term survival in transplanted patients was 89% and 80% at 5 and 10 years, respectively; but decreased to 47 % at 1 year and 18.2 % at 5 years once CLTI occurred. Conclusion Patients on HD program show a notorious risk of chronic limb threatening ischemia or amputation over time. Once this complication occurs, patient's survival is markedly reduced. Transplantation confers an independent protective effect over the development of chronic limb threatening ischemia or amputation.
引用
收藏
页码:784 / 790
页数:7
相关论文
共 50 条
  • [21] Tissue ischemia worsens during hemodialysis in end-stage renal disease patients
    Malik, Jan
    Kudlicka, Jaroslav
    Lachmanova, Jana
    Valerianova, Anna
    Rocinova, Katarina
    Bartkova, Magdalena
    Tesar, Vladimir
    JOURNAL OF VASCULAR ACCESS, 2017, 18 (01): : 47 - 51
  • [22] The Effect of Kidney Transplantation on Pulmonary Hypertension in End-stage Kidney Disease Patients on Hemodialysis
    Jane, Christine Mary
    Kumar, K. Vinod
    Kumar, R. Anil
    Unni, V. Narayanan
    Prasannan, Bipi K.
    Pullockara, Jojo K.
    Dev, U. R. S. Vishnu
    INDIAN JOURNAL OF TRANSPLANTATION, 2024, 18 (04)
  • [23] Efficacy of Revascularization for Critical Limb Ischemia in Patients with End-stage Renal Disease
    Yamamoto, S.
    Hosaka, A.
    Okamoto, H.
    Shigematsu, K.
    Miyata, T.
    Watanabe, T.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2014, 48 (03) : 316 - 324
  • [24] Impact of femoropopliteal bypass surgery on the survival and amputation rate of end-stage renal disease patients with critical limb ischemia
    Koch, Michael
    Trapp, Rudolf
    Hepp, Wolfgang
    MEDIZINISCHE KLINIK, 2007, 102 (02) : 107 - 111
  • [25] Obesity and risk of end-stage renal disease in patients with chronic kidney disease: a cohort study
    Lin, Ting-Yun
    Liu, Jia-Sin
    Hung, Szu-Chun
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2018, 108 (05): : 1145 - 1153
  • [26] Risk of end-stage renal disease among hepatitis C patients with chronic kidney disease treated with and without sofosbuvir
    Telep, Laura
    Sise, Meghan
    Force, Lindsey
    Gaggar, Anuj
    Chokkalingam, Anand
    JOURNAL OF HEPATOLOGY, 2020, 73 : S616 - S616
  • [27] Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death
    Lorien S. Dalrymple
    Ronit Katz
    Bryan Kestenbaum
    Michael G. Shlipak
    Mark J. Sarnak
    Catherine Stehman-Breen
    Stephen Seliger
    David Siscovick
    Anne B. Newman
    Linda Fried
    Journal of General Internal Medicine, 2011, 26 : 379 - 385
  • [28] Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patients
    Rosa-Diez, Guillermo
    Negri, Armando Luis
    Crucelegui, Maria Soledad
    Philippi, Romina
    Perez-Teysseyre, Hernan
    Sarabia-Reyes, Carmen
    Loor-Navarrete, Henry
    Heguilen, Ricardo
    CLINICAL KIDNEY JOURNAL, 2016, 9 (03): : 481 - 485
  • [29] Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death
    Dalrymple, Lorien S.
    Katz, Ronit
    Kestenbaum, Bryan
    Shlipak, Michael G.
    Sarnak, Mark J.
    Stehman-Breen, Catherine
    Seliger, Stephen
    Siscovick, David
    Newman, Anne B.
    Fried, Linda
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 (04) : 379 - 385
  • [30] A comparison of quality of sleep between patients with chronic kidney disease not on hemodialysis and end-stage renal disease on hemodialysis in a developing country
    Shafi, Salman T.
    Shafi, Tahir
    RENAL FAILURE, 2017, 39 (01) : 623 - 628